Company profile for Genocury

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Genocury Biotech founded in 2021 in Shenzhen, China, is a clinical-stage innovator in universal cell and gene therapies (CGT) for cancer and autoimmune diseases. Featuring advanced iPSC reprogramming/differentiation and in vivo targeted delivery platforms, key pipelines include lymphodepletion-free in vivo CD19 CAR-T (Vivoexpress™; CR in relapsed DLBCL within 28 days, NCT07059169) and iPS-derived CAR-iNK for scalable, afford...
Genocury Biotech founded in 2021 in Shenzhen, China, is a clinical-stage innovator in universal cell and gene therapies (CGT) for cancer and autoimmune diseases. Featuring advanced iPSC reprogramming/differentiation and in vivo targeted delivery platforms, key pipelines include lymphodepletion-free in vivo CD19 CAR-T (Vivoexpress™; CR in relapsed DLBCL within 28 days, NCT07059169) and iPS-derived CAR-iNK for scalable, affordable off-the-shelf treatments. Secured A+ funding from OrbiMed (2025); dedicated to accessible, insurance-covered CGT.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Room 1201, Building 1, Phase 1, Yinxing Zhijie, Guanlan Street, Longhua Distri...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Arvo

Arvo

Not Confirmed

envelop Contact Supplier

Arvo

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty